NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.

Health Care

Health Diagnostics

Hotels & Hospitality

Pharmaceutical

Therapeutics

NorthStar Medical Radioisotopes, LLC

Steve Merrick

Peter Keal

Doug Koehler

Stewart Winter

Samuel Nortman

Omar Nusair, PhD

Michael Allex

John Kunert

John Barnes

Aaron Robbins

Spencer Ortyn

Ryan Grayson

Paul Estrem

James Brodack

Dr. Frank Scholz

Dave Wilson

The Leadership Team at NorthStar Medical Radioisotopes, LLC is responsible for guiding the company's strategic direction and ensuring operational excellence in the production of medical isotopes. Comprising executives from various disciplines, including science, quality, corporate development, and manufacturing, the team collaborates to address industry challenges, enhance patient care, and drive innovation in nuclear medicine technologies. Their combined expertise supports effective decision-making and fosters a culture of safety, compliance, and continuous improvement within the organization.

Leadership Team

Engineering and Technical Support

Project Management

Leadership Team

About

Team members